RU2014145029A - A method for the prevention of cancer of the liver and esophagus in laboratory animals - Google Patents
A method for the prevention of cancer of the liver and esophagus in laboratory animals Download PDFInfo
- Publication number
- RU2014145029A RU2014145029A RU2014145029A RU2014145029A RU2014145029A RU 2014145029 A RU2014145029 A RU 2014145029A RU 2014145029 A RU2014145029 A RU 2014145029A RU 2014145029 A RU2014145029 A RU 2014145029A RU 2014145029 A RU2014145029 A RU 2014145029A
- Authority
- RU
- Russia
- Prior art keywords
- esophagus
- liver
- cancer
- prevention
- chemoprophylaxis
- Prior art date
Links
- 238000010171 animal model Methods 0.000 title claims abstract 3
- 210000003238 esophagus Anatomy 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title claims abstract 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 title 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
- 208000014018 liver neoplasm Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000005623 Carcinogenesis Diseases 0.000 claims abstract 2
- WBNQDOYYEUMPFS-UHFFFAOYSA-N N-nitrosodiethylamine Chemical compound CCN(CC)N=O WBNQDOYYEUMPFS-UHFFFAOYSA-N 0.000 claims abstract 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract 2
- 230000036952 cancer formation Effects 0.000 claims abstract 2
- 231100000504 carcinogenesis Toxicity 0.000 claims abstract 2
- 235000013305 food Nutrition 0.000 claims abstract 2
- 210000004185 liver Anatomy 0.000 claims abstract 2
- 229940016667 resveratrol Drugs 0.000 claims abstract 2
- 235000021283 resveratrol Nutrition 0.000 claims abstract 2
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Способ химиопрофилактики канцерогенеза печени и пищевода у экспериментальных животных, включающий одновременное введение средства химиопрофилактики в течение 6 месяцев и N-нитрозодиэтиламина в течение 4 месяцев, отличающийся тем, что в качестве химиопрофилактического средства применяют препарат ресвератрол, вводимый ежедневно с пищей в дозе 100 мг/кг.A method for chemoprophylaxis of carcinogenesis of the liver and esophagus in experimental animals, comprising the simultaneous administration of a chemoprophylaxis for 6 months and N-nitrosodiethylamine for 4 months, characterized in that resveratrol is administered as a chemoprophylaxis, administered daily with food at a dose of 100 mg / kg .
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014145029A RU2014145029A (en) | 2014-11-06 | 2014-11-06 | A method for the prevention of cancer of the liver and esophagus in laboratory animals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014145029A RU2014145029A (en) | 2014-11-06 | 2014-11-06 | A method for the prevention of cancer of the liver and esophagus in laboratory animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014145029A true RU2014145029A (en) | 2016-05-27 |
Family
ID=56095806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014145029A RU2014145029A (en) | 2014-11-06 | 2014-11-06 | A method for the prevention of cancer of the liver and esophagus in laboratory animals |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2014145029A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699932C1 (en) * | 2018-11-14 | 2019-09-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method for prediction of liver cancer risk in experimental animals |
| RU2736238C1 (en) * | 2020-05-12 | 2020-11-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method for assessing the effectiveness of chemopreventive activity of resveratrol in experimental carcinogenesis of liver cancer |
-
2014
- 2014-11-06 RU RU2014145029A patent/RU2014145029A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699932C1 (en) * | 2018-11-14 | 2019-09-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method for prediction of liver cancer risk in experimental animals |
| RU2736238C1 (en) * | 2020-05-12 | 2020-11-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method for assessing the effectiveness of chemopreventive activity of resveratrol in experimental carcinogenesis of liver cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021003230A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM. | |
| CY1125205T1 (en) | ACTIVE PHARMACEUTICAL COMPOSITIONS FROM THE THERAPEUTIC POINT OF VIEW OF COMPOUNDS | |
| JOP20160092B1 (en) | Treatment of beta thalassemia using a ligne tray | |
| TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
| MX2020011104A (en) | Pharmaceutical compositions of therapeutically active compounds. | |
| CY1121554T1 (en) | PRODUCER OF PYRANOCHROMENYL-PHENOLIS, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME OR INFLAMMATORY DISEASE | |
| EA202090683A3 (en) | METHODS AND COMPOSITIONS FOR CANCER TREATMENT | |
| EP3111931A4 (en) | Pharmaceutical composition for cancer treatment containing gossypol and phenformin as active ingredients | |
| CR20180253A (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN UNMUNODEFICIENCY VIRUS | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| BR112017012406A2 (en) | fixed ratio formulation of insulin glargine / lixisenatide | |
| MX392470B (en) | PHARMACEUTICAL COMPOSITION COMPRISING A WT1 PEPTIDE FOR THE TREATMENT OR PREVENTION OF AN ANGIOGENIC DISEASE. | |
| EA201790726A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12017502046A1 (en) | Salts and prodrugs of 1-methyl-d-tryptophan | |
| EP3868385A4 (en) | STOMACH CANCER TREATMENT COMPOSITION WITH SYT11 INHIBITOR AS THE ACTIVE INGREDIENT | |
| PH12016502243A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
| EA201890457A1 (en) | COMBINATION ANTIBODY AGAINST THE OX40 AND THE TLR4 MODULATOR AND THEIR APPLICATION | |
| CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| BR112018006206A2 (en) | composition, use of a combination, pharmaceutical fixed dosage form, fixed dosage combination, packaging, and use of a fixed dose combination | |
| RU2014145029A (en) | A method for the prevention of cancer of the liver and esophagus in laboratory animals | |
| EA201890929A1 (en) | LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE | |
| WO2016072692A3 (en) | Composition for preventing or treating mucositis comprising necrox as effective ingredient | |
| AR106415A1 (en) | PHARMACEUTICAL COMPOSITION FOR PAIN TREATMENT |